Unicycive Therapeutics, Inc.
UNCY
$5.12
$0.091.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.72M | -12.82M | -14.67M | -6.01M | -6.45M |
| Total Depreciation and Amortization | 151.00K | 211.00K | 151.00K | 148.00K | 138.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.13M | 5.56M | 8.55M | -337.00K | 197.00K |
| Change in Net Operating Assets | -900.00K | 807.00K | -2.06M | 237.00K | -2.31M |
| Cash from Operations | -7.60M | -6.24M | -8.03M | -5.96M | -8.42M |
| Capital Expenditure | 1.00K | -8.00K | 0.00 | -2.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.00K | -5.15M | -12.07M | -- | -- |
| Cash from Investing | -23.00K | -5.16M | -12.07M | -2.00K | -6.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.89M | 20.17M | 6.81M | 27.15M | 11.33M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -447.00K | -605.00K | -205.00K | -815.00K | -346.00K |
| Cash from Financing | 14.44M | 19.57M | 6.61M | 26.33M | 10.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.81M | 8.17M | -13.50M | 20.37M | 2.56M |